Literature DB >> 17211402

Lentiviral vectors ready for prime-time.

Donald B Kohn.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17211402     DOI： 10.1038/nbt0107-65

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  16 in total

Review 1.  The use of cell-delivered gene therapy for the treatment of HIV/AIDS.

Authors:  Geoff P Symonds; Helen A Johnstone; Michelle L Millington; Maureen P Boyd; Bryan P Burke; Louis R Breton
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 2.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

3.  Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.

Authors:  Chi-Lin Lee; Jason Dang; Kye-Il Joo; Pin Wang
Journal:  Virus Res       Date:  2011-07-23       Impact factor: 3.303

4.  Toward synthetic biology with engineered T cells: a long journey just begun.

Authors:  Carl H June
Journal:  Hum Gene Ther       Date:  2014-09       Impact factor: 5.695

5.  Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.

Authors:  Biliang Hu; Haiguang Yang; Bingbing Dai; April Tai; Pin Wang
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

Review 6.  Cardiovascular gene therapy for myocardial infarction.

Authors:  Maria C Scimia; Anna M Gumpert; Walter J Koch
Journal:  Expert Opin Biol Ther       Date:  2013-12-16       Impact factor: 4.388

7.  Site-specific labeling of enveloped viruses with quantum dots for single virus tracking.

Authors:  Kye-Il Joo; Yuning Lei; Chi-Lin Lee; Jonathon Lo; Jiansong Xie; Sarah F Hamm-Alvarez; Pin Wang
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

8.  Targeting lentiviral vectors to antigen-specific immunoglobulins.

Authors:  Leslie Ziegler; Lili Yang; Kye il Joo; Haiguang Yang; David Baltimore; Pin Wang
Journal:  Hum Gene Ther       Date:  2008-09       Impact factor: 5.695

9.  Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition.

Authors:  S Yang; C J Cohen; P D Peng; Y Zhao; L Cassard; Z Yu; Z Zheng; S Jones; N P Restifo; S A Rosenberg; R A Morgan
Journal:  Gene Ther       Date:  2008-05-22       Impact factor: 5.250

10.  Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.

Authors:  Shicheng Yang; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunother       Date:  2008 Nov-Dec       Impact factor: 4.456
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.